Trulicity vs. Glimepiride

See how Trulicity and Glimepiride compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Trulicity is a once-weekly injectable GLP-1 that also lowers cardiovascular risk, while glimepiride is a once-daily pill that only targets blood sugar.

  • Glimepiride costs far less than Trulicity but carries a higher risk of hypoglycemia and possible weight gain.

  • Trulicity is approved for children 10 and older, while glimepiride is approved for adults with type 2 diabetes only.

Trulicity vs. Glimepiride Drug Summary

Trulicity

Trulicity (dulaglutide) is a GLP-1 receptor agonist that helps the body release more insulin after meals and slows digestion. It treats type 2 diabetes in adults and children 10 and older, and also lowers cardiovascular risk in adults with heart disease. It is injected once a week using a prefilled pen.

Glimepiride

Glimepiride is a sulfonylurea that stimulates the pancreas to release more insulin throughout the day. It is approved to help adults with type 2 diabetes control blood sugar alongside diet and exercise. It comes as a tablet taken once daily, usually with the first main meal.

Trulicity vs. Glimepiride Side Effects

Trulicity

Most common
nausea (up to 21.1%)
diarrhea (up to 13%)
vomiting (up to 13%)
abdominal pain (up to 13%)

Glimepiride

Most common
hypoglycemia (>5%)
dizziness (>5%)
asthenia (>5%)
headache (>5%)

Trulicity vs. Glimepiride Dosage

Trulicity

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.75 mg once weekly Weeks 1-4
Maximum dose 4.5 mg once weekly Week 13 onward
Dose changes 3 increases Every 4 weeks

Glimepiride

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 1 mg once daily At the start
Maximum dose 8 mg once daily If needed
Dose changes 3 increases As tolerated

Trulicity vs. Glimepiride Indications

Trulicity

Trulicity is FDA-approved to improve blood sugar control in adults and children 10 and older with type 2 diabetes. It also reduces the risk of major cardiovascular events in adults with heart disease or multiple risk factors. It is sometimes used off-label for weight loss in people without diabetes.

  • Blood sugar control in type 2 diabetes (adults and children 10+)

  • Cardiovascular risk reduction in adults with heart disease or risk factors

  • Off-label: weight loss in people without diabetes

  • Not approved for type 1 diabetes or diabetic ketoacidosis

Glimepiride

Glimepiride is FDA-approved to improve blood sugar control in adults with type 2 diabetes, used alongside diet and exercise. It does not carry an approved cardiovascular, weight-loss, or pediatric indication, unlike some newer diabetes drugs. It is not approved for type 1 diabetes or diabetic ketoacidosis.

  • Blood sugar control in adults with type 2 diabetes

  • Used as an adjunct to diet and exercise

  • Not approved for type 1 diabetes or diabetic ketoacidosis

  • No pediatric or cardiovascular indication

Trulicity vs. Glimepiride Pros and Cons

Trulicity

Trulicity offers once-weekly dosing and added cardiovascular protection, but it requires an injection and carries a boxed warning for thyroid tumors seen in animal studies. There is no generic version, and it costs substantially more than older oral options like glimepiride.

Pros

  • Only needs to be injected once a week

  • Also reduces cardiovascular risk in adults with heart disease

  • Approved for children as young as 10

  • Low risk of causing hypoglycemia on its own

Cons

  • Requires an injection instead of a pill

  • Boxed warning for thyroid C-cell tumors seen in animal studies

  • No generic version is available

  • Roughly $987 to $1,065 per month without insurance

  • Common GI side effects like nausea and vomiting

Glimepiride

Glimepiride is a low-cost oral option with decades of real-world use, but it works differently than Trulicity and carries a higher risk of hypoglycemia. It has no cardiovascular or weight-related benefit, and some studies have linked sulfonylureas to increased cardiovascular mortality risk.

Pros

  • Costs roughly $10 to $20 per month without insurance

  • Convenient once-daily tablet

  • Long track record of use since 1995

  • Generic pricing makes it widely accessible

Cons

  • Higher risk of hypoglycemia than Trulicity

  • Can cause weight gain

  • Possible increased cardiovascular mortality risk (UGDP study)

  • No cardiovascular protection benefit

  • Not approved for use in children

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.